关注
Samuel R Friedman
Samuel R Friedman
在 ndri.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
The social structural production of HIV risk among injecting drug users
T Rhodes, M Singer, P Bourgois, SR Friedman, SA Strathdee
Social science & medicine 61 (5), 1026-1044, 2005
11322005
Structural interventions: concepts, challenges and opportunities for research
KM Blankenship, SR Friedman, S Dworkin, JE Mantell
Journal of Urban Health 83, 59-72, 2006
6432006
Reducing the risk of AIDS through methadone maintenance treatment
JC Ball, WR Lange, CP Myers, SR Friedman
Journal Of Health and social behavior, 214-226, 1988
6291988
Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial
DC Des Jarlais, D Paone, J Milliken, CF Turner, H Miller, J Gribble, Q Shi, ...
The Lancet 353 (9165), 1657-1661, 1999
6281999
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987
DC Des Jarlais, SR Friedman, DM Novick, JL Sotheran, P Thomas, ...
Jama 261 (7), 1008-1012, 1989
5521989
HIV incidence among injecting drug users in New York City syringe-exchange programmes
DC Des Jarlais, M Marmor, D Paone, S Titus, Q Shi, T Perlis, B Jose, ...
The Lancet 348 (9033), 987-991, 1996
5251996
Sociometric risk networks and risk for HIV infection.
SR Friedman, A Neaigus, B Jose, R Curtis, M Goldstein, G Ildefonso, ...
American journal of public health 87 (8), 1289-1296, 1997
4211997
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.
M Marmor, DC Des Jarlais, H Cohen, SR Friedman, ST Beatrice, N Dubin, ...
AIDS (London, England) 1 (1), 39-44, 1987
4201987
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users
DONCDES JARLAIS, SR Friedman, W Hopkins
Annals of Internal Medicine 103 (5), 755-759, 1985
4091985
The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection
A Neaigus, SR Friedman, R Curtis, DC Des Jarlais, RT Furst, B Jose, ...
Social science & medicine 38 (1), 67-78, 1994
4011994
Maintaining low HIV seroprevalence in populations of injecting drug users
DC Des Jarlais, H Hagan, SR Friedman, P Friedmann, D Goldberg, ...
Jama 274 (15), 1226-1231, 1995
3671995
HIV infection among intravenous drug users: epidemiology and risk reduction.
DC Des Jarlais, SR Friedman
AIDS (London, England) 1 (2), 67-76, 1987
3531987
Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.
H Hagan, DC Jarlais, SR Friedman, D Purchase, MJ Alter
American Journal of Public Health 85 (11), 1531-1537, 1995
3361995
AIDS and self-organization among intravenous drug users
SR Friedman, DC Des Jarlais, JL Sotheran, J Garber, H Cohen, D Smith
International Journal of the Addictions 22 (3), 201-219, 1987
3221987
International epidemiology of HIV and AIDS among injecting drug users
DC Des Jarlais, SR Friedman, K Choopanya, S Vanichseni, TP Ward
Aids 6 (10), 1053-1068, 1992
3071992
Continuity and change within an HIV epidemic: injecting drug users in New York City, 1984 through 1992
DC Des Jarlais, SR Friedman, JL Sotheran, J Wenston, M Marmor, ...
Jama 271 (2), 121-127, 1994
2881994
A larger spectrum of severe HIV-1—related disease in intravenous drug users in New York City
RL Stoneburner, DC Des Jarlais, D Benezra, L Gorelkin, JL Sotheran, ...
Science 242 (4880), 916-919, 1988
2801988
HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention
DC Des Jarlais, SR Friedman, RL Stoneburner
Reviews of infectious diseases 10 (1), 151-158, 1988
2681988
Social networks, risk-potential networks, health, and disease
SR Friedman, S Aral
Journal of Urban Health 78, 411-418, 2001
2522001
Social networks, drug injectors’ lives, and HIV
SR Friedman, R Curtis, A Neaigus, B Jose, DC Des Jarlais
Aids 1, 1999
2501999
系统目前无法执行此操作,请稍后再试。
文章 1–20